Something unsettling is happening in medicine, and many of us feel it even if we haven’t said it out loud: evidence-based medicine is slowly being eroded, not just by outsiders, but from within our own profession.

Patients today are searching more than ever before for quick fixes, and physicians are increasingly stepping into the marketplace to meet that demand. Hormone pellets. “Longevity protocols.” Peptides that sound scientific but have no real human data behind them. The trend is unmistakable. And it should worry all of us.

As physicians, we were trained to recommend treatments based on safety, efficacy, and evidence. Somehow that standard is being diluted by the allure of new revenue streams, patient demand for instant results, and the pressure to stay “competitive” in an unrecognizable health care landscape.

But medicine was never supposed to be about being competitive. It was supposed to be about being careful.

The rise of the quick fix and physicians as influencers

Patients are frustrated. They want relief. They want hope. They want results yesterday. And in an era of social media medicine, convenience often wins over caution.

But now it’s not just influencers promoting shortcuts. Physicians are increasingly selling:

• Testosterone pellets to women, despite limited and inconsistent safety data
• Expensive hormone “optimization” programs
• Compounded longevity stacks
• And most recently, injectable peptides, many of which have zero peer-reviewed human studies and no established therapeutic dose

These clinics are growing because the demand exists. But demand is not the same as evidence. And popularity is not the same as safety.

What happened to “first, do no harm”?

Somewhere along the way, primum non nocere became negotiable.

We stopped asking the questions that matter: Is it effective? Is it safe? Is the risk worth the potential benefit? Do we actually know the long-term consequences?

For many of these modern “wellness” interventions, the honest answer is: We don’t know.

And, medicine should never operate on we don’t know.

Consider peptides, now a booming industry. Most are marketed with extraordinary claims: tissue healing, fat loss, anti-aging, gut repair, muscle building. But beneath the hype is a stark truth:

• There are no robust human clinical trials supporting these claims.
• There are no established safe doses.
• Regulatory agencies classify many of them as unapproved drugs.
• And the long-term risks are not just unclear, they’re unknown.

Yet they’re being sold widely, often packaged as “cutting-edge medicine.” Cutting-edge compared to what? Certainly not compared to actual scientific rigor.

HRT vs. hormone pellets: a lesson in contrast

Take hormone therapy. There is strong evidence supporting appropriate, individualized HRT in women. We now have decades of data, evolving guidelines, and a nuanced understanding of risk.

Then there are hormone pellets, a popular cash-pay option often promoted to women as a superior alternative. But the evidence doesn’t match the marketing:

• Limited long-term safety data
• Variable dosing
• No way to reverse once placed
• And little standardization or protocols

Yet pellets are offered as if they are a proven standard of care. They aren’t. This isn’t innovation. It’s improvisation.

Why this matters

The erosion of evidence-based practice is not just an intellectual concern; it’s a patient safety issue and a professional identity issue. When physicians endorse therapies without solid data, we expose patients to unknown risks. We weaken public trust in our profession. And we become a salesperson, not a clinician.

Medicine loses something every time we prioritize trends over truth. Innovation is important. Curiosity is essential. Emerging therapeutics are exciting. But none of it replaces evidence.

If we abandon caution, if we stop demanding data, if we let commerce drive practice, then yes, evidence-based medicine may very well die. It won’t be a dramatic collapse, but rather a slow fall, through a thousand small compromises.

Corinne Rao is an internal medicine physician, working as an independent contractor at several health care facilities, the owner of an internal medicine practice, and a member of FlexMedstaff. In her spare time, she is a ballroom dancer.